fluorodeoxyuridylate has been researched along with sb 218078 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gmeiner, WH; Jennings-Gee, J; Pardee, TS | 1 |
1 other study(ies) available for fluorodeoxyuridylate and sb 218078
| Article | Year |
|---|---|
Replication-dependent irreversible topoisomerase 1 poisoning is responsible for FdUMP[10] anti-leukemic activity.
Topics: Alkaloids; Antimetabolites, Antineoplastic; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; DNA Breaks, Double-Stranded; DNA Replication; DNA Topoisomerases, Type I; DNA, Neoplasm; Fluorodeoxyuridylate; HL-60 Cells; Humans; Leukemia, Monocytic, Acute; Leukemia, Promyelocytic, Acute; S Phase; Thymidylate Synthase; Thymine; Topoisomerase Inhibitors | 2013 |